# Office of Pharmaceutical Quality Operations

Source: https://www.keypedia.com/offices/office-of-pharmaceutical-quality-operations/6b0153a9-c1d1-46a5-8b10-836d2ae44ffe
Abbreviation: OPQO
Location: Rockville, Maryland, USA

---

## Details

- Sub Administrative Area: MD
- Postal Code: 20857
- Thoroughfare: 12420 Parklawn Drive
- Sub Premise: Room 2032
- Office URL: https://www.fda.gov/about-fda/cder-offices-and-divisions/office-pharmaceutical-quality
- Created At: 2024-09-13T03:04:10+00:00

## Records at this office

- [Shandong Anhong Pharmaceutical Co., Ltd.](https://www.keypedia.com/records/483/shandong-anhong-pharmaceutical-co-ltd/f5496f60-3dfc-46fe-aab5-0905d76562a6) — date: June 26, 2026
- [Intas Pharmaceuticals Ltd.](https://www.keypedia.com/records/483/intas-pharmaceuticals-ltd/80904191-e341-4855-ab11-f5e543dc08e3) — date: September 17, 2025
- [Biocon Biologics Limited](https://www.keypedia.com/records/483/biocon-biologics-limited/c07dd3b0-1ac3-4459-ad58-5a96848e65fb) — date: September 3, 2025
- [Ajinomoto Co. Inc. Kyushu Plant](https://www.keypedia.com/records/483/ajinomoto-co-inc-kyushu-plant/10f3e0f6-8d48-419e-bea1-8b0587ce02e4) — date: July 18, 2025
- [Baxter Oncology GmbH](https://www.keypedia.com/records/eir/baxter-oncology-gmbh/926cf150-be1f-4e3c-8bcc-c1595173865d) — date: August 27, 2024
- [Cipla, Ltd.](https://www.keypedia.com/records/483/cipla-ltd/49e75f7a-9d48-4aab-b5d8-fcdacd62e11c) — date: May 8, 2024
- [Zydus Lifesciences Limited](https://www.keypedia.com/records/483/zydus-lifesciences-limited/9082a7d8-9d0d-46f0-bbdd-3911d03fa272) — date: March 27, 2024
- [Eugia SEZ Private Limited](https://www.keypedia.com/records/483/eugia-sez-private-limited/c9950ab3-3852-4ab3-a977-1234b0111d75) — date: February 29, 2024
- [SUMAR BIOTECH LLP](https://www.keypedia.com/records/483/sumar-biotech-llp/bdba03f3-f0e1-4aa8-b013-44aec363460f) — date: January 12, 2024
- [Nanchang Anobri Pharmaceutical CO., LTD](https://www.keypedia.com/records/483/nanchang-anobri-pharmaceutical-co-ltd/e6abb269-d7ab-4d54-b1d7-f126127d5e13) — date: November 13, 2023
- [Ote Pharma Sol B.V.](https://www.keypedia.com/records/eir/ote-pharma-sol-bv/1c27ac5c-da0e-435c-8e76-3b9f4ecf219b) — date: September 15, 2023
- [APARNA ORGANICS LIMITED](https://www.keypedia.com/records/483/aparna-organics-limited/2f68d350-68f3-40c7-a3c7-e442203e9554) — date: September 11, 2023
- [National Chemical Laboratories](https://www.keypedia.com/records/warning_letter/national-chemical-laboratories/1b821dfc-bc1a-4407-be9a-2a5af5ca8869) — date: May 26, 2023
- [Keshava Organics Private Ltd.](https://www.keypedia.com/records/483/keshava-organics-private-ltd/2d64611a-9188-481e-ba3d-aeb7e534ce08) — date: January 13, 2023
- [Intas Pharmaceuticals Limited](https://www.keypedia.com/records/483/intas-pharmaceuticals-limited/aaef987c-6382-4641-8d0e-9fc48ace87ba) — date: December 2, 2022
- [Torrent Pharmaceuticals Limited](https://www.keypedia.com/records/483/torrent-pharmaceuticals-limited/f89540c1-5fb6-42ce-aa14-b1486fc75b28) — date: September 28, 2022
- [KBI Biopharma, Inc.](https://www.keypedia.com/records/eir/kbi-biopharma-inc/30c356bd-9d01-4bab-921c-1b4df3651548) — date: January 13, 2022
- [Ultra Seal Corporation](https://www.keypedia.com/records/warning_letter/ultra-seal-corporation/5ebe402b-ba7d-4c9e-a403-8542e6bf2368) — date: September 14, 2021
- [Yung Shin Pharmaceutical Industry Co., Ltd.](https://www.keypedia.com/records/eir/yung-shin-pharmaceutical-industry-co-ltd/3cfe7849-7804-4b9b-a644-098161ee5f25) — date: June 21, 2021
- [Kreative Organics Private Limited](https://www.keypedia.com/records/483/kreative-organics-private-limited/f59c7849-6886-4ec6-8200-40281b635fbe) — date: February 7, 2020

_40 total records — see https://www.keypedia.com/offices/office-of-pharmaceutical-quality-operations/6b0153a9-c1d1-46a5-8b10-836d2ae44ffe for paginated browsing._

## Related Offices

- [Office of Compliance Intervention and Consultation](https://www.keypedia.com/offices/office-of-compliance-intervention-and-consultation/0b3cfe41-f423-41e0-b1a1-caab23b32d54)
- [Acting Division Director](https://www.keypedia.com/offices/acting-division-director/94758cee-45fe-4207-8c63-497d74b732b6)
- [Bureau of Environmental Health](https://www.keypedia.com/offices/bureau-of-environmental-health/87a06a18-caf6-42b9-8dd5-f53ec7a64384)
- [Division of Nonprescription Drug Products](https://www.keypedia.com/offices/division-of-nonprescription-drug-products/f89a77f0-4378-476b-b846-97563e1b959d)
- [Division of Reproductive and Urologic Products](https://www.keypedia.com/offices/division-of-reproductive-and-urologic-products/29137540-95d5-48bc-a13a-501ed2bf9c3f)

## Officers

- [Program Expert](https://www.keypedia.com/people/thomas-r-berry/d162384e-0291-4ae8-bce1-564dafd4d798)
- [John W. Diehl, M.S.Program Division](https://www.keypedia.com/people/john-w-diehl/83ce50c4-b3cb-42ca-96eb-0c988068e08f)
- [Consumer Safety Officer](https://www.keypedia.com/people/darren-s-brown/389a4d1f-7f34-42cd-bdc8-5bebd41aff56)
- [Liatte Krueger](https://www.keypedia.com/people/liatte-krueger/cbfda638-7610-43d9-9301-2e010665c86d)
- [Compliance Officer](https://www.keypedia.com/people/juan-jimenez/bfee2e60-a9f4-4b02-9b6d-08353ff1a401)
- [Director](https://www.keypedia.com/people/alonza-e-cruse/650e3631-3f99-45f7-863e-3a35c44be485)
- [Program Division Director](https://www.keypedia.com/people/art-o-czabaniuk/37f1e249-9ee6-4275-9c28-391d93659b85)
- [Compliance Officer](https://www.keypedia.com/people/rebecca-asente/0a82a46d-3e13-4a51-8abe-58955bb0095e)